© Reuters. FILE PHOTO: Medical employees put together Moderna coronavirus (COVID-19) vaccine to be administered at newly-opened mass vaccination centre in Tokyo, Japan, May 24, 2021. Carl Court/Pool by way of REUTERS
(Reuters) -Moderna Inc mentioned on Monday its COVID-19 vaccine generated a powerful immune response and was typically well-tolerated in children aged six to 11 years, citing interim information from a research.
The firm mentioned it deliberate to submit the information to U.S., European and different regulators quickly.
Moderna (NASDAQ:) mentioned the information confirmed two 50 microgram doses of the vaccine, half the power of the doses used in the vaccine given to adults, generated virus-neutralizing antibodies in children.
The majority of unintended effects had been delicate or average in severity, the corporate mentioned. The commonest solicited adversarial occasions had been fatigue, headache, fever and injection web site ache.
Fusion Media or anybody concerned with Fusion Media is not going to settle for any legal responsibility for loss or injury because of reliance on the knowledge together with information, quotes, charts and purchase/promote indicators contained inside this web site. Please be absolutely knowledgeable relating to the dangers and prices related to buying and selling the monetary markets, it is among the riskiest funding varieties doable.